Discover the transformative potential of ADHD medications in addiction treatment as we bring you a captivating discussion with Dr. Justin Mohatt, a renowned child and adolescent psychiatrist. Dr. Mohatt joins us to unravel the complexities of using ADHD medications to combat stimulant addiction, shedding light on how these drugs can make a difference. We'll explore a myriad of medications, including guanfacine, clonidine, and atomoxetine, and discuss their respective roles in addressing adult ADHD and substance use disorders. Learn the importance of a meticulous diagnostic process to distinguish ADHD from other mental health conditions like depression and anxiety, ensuring a tailored approach to treatment.

We navigate the nuanced landscape of ADHD in adults with a history of substance use, emphasizing the critical role of family insights to inform diagnoses beyond self-reports. The conversation underscores the careful application of stimulants for ADHD, even in those with stimulant use disorders, while presenting Vyvanse as a potentially safer choice. Non-stimulant medications like atomoxetine receive special attention for their dual role in treating ADHD and co-occurring anxiety, offering a glimpse into strategies for managing side effects and insurance hurdles. Hear how non-addictive alternatives could provide solutions for patients who haven't found success with traditional medications.

As we delve deeper into co-occurring ADHD and trauma, Dr. Mohatt discusses the potential benefits of alpha agonists and other non-stimulant options in treating complex cases involving PTSD and substance use disorders. Together, Dr. Mohatt and I affirm the importance of addressing ADHD within addiction treatment to foster recovery and improve cognitive function, offering a beacon of hope for those navigating these intertwined challenges.

To contact Dr. Grover: [email protected]